metricas
covid
Buscar en
Cirugía Española
Toda la web
Inicio Cirugía Española Seguimiento del cáncer colorrectal
Información de la revista
Vol. 73. Núm. 1.
Páginas 58-62 (enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 73. Núm. 1.
Páginas 58-62 (enero 2003)
Acceso a texto completo
Seguimiento del cáncer colorrectal
Folow-up of colorectal cancer
Visitas
11305
Matilde Navarro1, Josep Maria Piulats
Institut Català d’Oncologia. Barcelona. España.
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen

El seguimiento del cáncer colorrectal forma parte de nuestra práctica clínica, pese a existir una importante controversia sobre el número de visitas, qué pruebas utilizar y si estas estrategias tienen un impacto sobre la supervivencia. Todas estas preguntas se han intentado responder mediante varios estudios que incluyen metaanálisis, ensayos aleatorios y estudios de cohortes. Estos resultados han llevado al desarrollo de unas guías de práctica clínica por las sociedades oncológicas más importantes. En este capítulo revisaremos estos estudios y guías de práctica clínica para a continuación exponer nuestra experiencia con una cohorte de 399 pacientes seguidos de forma homogénea en nuestro centro.

Palabras clave::
Cáncer colorrectal
Supervivencia
Seguimiento
CEA

It is common clinical practise to follow patients with colorectal cancer for several years following their definitive surgery and adjuvant therapy. Despite this practice there is considerable controversy about how often should be seen, what tests should be performed and whether these varying strategies have any significant impact on patient outcomes. These frequency and modality of testing have been evaluated in many studies, including meta-analyses, prospective randomized trials, and cohort studies. These results have led to the development of practice guidelines by important societies for the follow-up of patients treated for colorectal cancers. In this paper are reviewed those studies and practice guidelines, after that we will explain our experience with a cohort of 399 patients followed according a well-defined postoperative surveillance program.

Key words:
Colorectal cancer
Surveillance
Follow-up
CEA
El Texto completo está disponible en PDF
Bibliografía
[1.]
B. Ohlsson, U. Breland, H. Ekberg, H. Graffner, K.G. Tranberg.
Followup after curative surgery for colorectal carcinoma: randomized comparison with no follow-up.
Dis Colon Rectum, 38 (1995), pp. 619-626
[2.]
B.J. Kjeldsen, O. Kronborg, C. Fenger, O.D. Jorgensen.
A prospective randomized study of follow-up after radical surgery for colorectal cancer.
Br J Surg, 84 (1997), pp. 666-669
[3.]
D. Schoemaker, R. Black, L. Giles, J. Toouli.
Yearly colonoscopy, liver CT and chest radiograph do not influence 5-year survival of colorectal cancer patients.
Gastroenterology, 114 (1998), pp. 7-14
[4.]
J.T. Makela, S.O. Laitinen, M.I. Kairaluoma.
Five year follow-up after radical surgery for colorectal cancer: results of a prospective randomized trial.
Arch Surg, 130 (1995), pp. 1062-1067
[5.]
G.B. Secco, R. Fardelli, D. Gianquinto, P. Bonfante, E. Baldi, et al.
Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial.
Eur J Surg Oncol, 28 (2002), pp. 418-423
[6.]
A. Castells, X. Bessa, M. Daniels, C. Ascaso, A.M. Lacy, et al.
Value of postoperative surveillance after radical surgery for colorectal cancer: result of a cohort study.
Dis Colon Rectum, 41 (1998), pp. 714-723
[7.]
D.J. Bruinvels, A.M. Stiggelbout, J. Kievit, H.C. Van Houwelingen, J.D. Habbema, et al.
Follow-up of patients with colorectal cancer. A meta-analysis.
Ann Surg, 219 (1994), pp. 174-182
[8.]
M. Rosen, L. Chan, R.W. Beart, P. Vukasin, G. Anthone.
Follow-up of colorectal cancer: a meta-analysis.
Dis Colon Rectum, 41 (1998), pp. 1116-1126
[9.]
A.G. Renehan, M. Egger, M.P. Saunders, S.T. O’Dwyer.
Impact on survival of intensive follow-up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials.
BMJ, 324 (2002), pp. 1-8
[10.]
C.E. Desch, A.B. Benson, T.J. Smith, P.J. Flynn, C. Krause.
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology.
J Clin Oncol, 17 (1999), pp. 1312-1321
[11.]
P.F. Engstrom, A.B. Benson, A. Cohen, J. Doroshow, K. Kiel, et al.
NCCN colorectal cancer practice guidelines: the National Comprehensive Cancer Network.
Oncology (Huntingt, 10 (1996), pp. 140-175
[12.]
ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer.
Ann Oncol, 12 (2001), pp. 1053-1054
[13.]
F. Safi, H.G. Beyer.
The value of follow-up after curative surgery of colorectal carcinoma.
Cancer Detect Prev, 17 (1993), pp. 417-424
[14.]
B.D. Minsky, C. Mies, A. Recht.
Resectable adenocarcinoma of the rectosigmoid and rectum: patterns of failure and survival.
Cancer, 61 (1998), pp. 1408-1416
[15.]
B. Fisher, K. Wolmar, H. Rockett, C. Redmond, M. Deutsch, et al.
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.
J Natl Cancer Inst, 80 (1998), pp. 21-29
[16.]
P. Flamen, O.S. Hoekstra, F. Homans, E. Van Cutsem, A. Maes, et al.
Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET.
Eur J Cancer, 37 (2001), pp. 862-869
[17.]
M.W. Wichmann, C. Müller, H.M. Hornung, U. Lau-Werner, F.W. Schildberg.
Results of long-term follow-up after curative resection of Dukes A colorectal cancer.
World J Surg, 26 (2002), pp. 732-736
[18.]
C.G. Moertel, T.R. Fleming, J.S. Macdonald, D.G. Haller, J.A. Laurie, et al.
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.
JAMA, 270 (1993), pp. 943-947
[19.]
R.C. Bast, P. Ravdin, D.F. Hayes, S. Bates, H. Fritsche, et al.
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.
J Clin Oncol, 19 (2001), pp. 1865-1878
[20.]
F.L. Flanagan, F. Dehdashti, O.A. Ogunbiyi, I.J. Kodner, B.A. Siegel.
Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer.
Ann Surg, 227 (1998), pp. 319-323
[21.]
Urruticoechea A, Navarro M, Majem M, Pareja L, Martí-Ragué JThe value of follow-up in resecable colorectal cancer after adju-
Copyright © 2003. Asociación Española de Cirujanos
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos